Jacob translates scientific innovation into clinical interventions. He completed his medical degree from the HST Program at Harvard Medical School and his PhD in neuroscience from MIT, where his research focused on computational neurophysiology and the effects of neuroactive compounds on brain network activity. His published works span epilepsy, cognition and machine learning methods for quantifying pharmacological effects on neural activity. Jake co-founded Beacon Biosignals, the worlds leading computational neurodiagnostics company, to harness machine learning to unlock the power of EEG data in order to advance precision medicines for neurologic and psychiatric disorders.
William Oh, Mount Sinai